Schilling WHK, Jittamala P, Watson JA, Boyd S, et al. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. Lancet Infect Dis 2023 Sep 28:S1473-3099(23)00493.
PMID: 37778363